Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific (SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral immunity against the virus is not durable. If immunity wanes quickly, millions of people may be at risk for reinfection after recovery from coronavirus disease 2019 (COVID-19). However, memory B cells (MBCs) could provide durable humoral immunity even if serum neutralizing antibody titers decline. We performed multidimensional flow cytometric analysis of S protein receptor binding domain–specific (S-RBD–specific) MBCs in cohorts of ambulatory patients with COVID-19 with mild disease (n = 7), and hospitalized patients with moderate to severe disease (n = 7), at a median of 54 days (range, 39–104 days) after symptom onset. We detected S-RBD–specific class-switched MBCs in 13 of 14 participants, failing only in the individual with the lowest plasma levels of anti–S-RBD IgG and neutralizing antibodies. Resting MBCs (rMBCs) made up the largest proportion of S-RBD–specific MBCs in both cohorts. FCRL5, a marker of functional memory on rMBCs, was more dramatically upregulated on S-RBD–specific rMBCs after mild infection than after severe infection. These data indicate that most SARS-CoV-2-infected individuals develop S-RBD–specific, class-switched rMBCs that resemble germinal center–derived B cells induced by effective vaccination against other pathogens, providing evidence for durable B cell–mediated immunity against SARS-CoV-2 after mild or severe disease.
Clinton O. Ogega, Nicole E. Skinner, Paul W. Blair, Han-Sol Park, Kirsten Littlefield, Abhinaya Ganesan, Santosh Dhakal, Pranay Ladiwala, Annukka A.R. Antar, Stuart C. Ray, Michael J. Betenbaugh, Andrew Pekosz, Sabra L. Klein, Yukari C. Manabe, Andrea L. Cox, Justin R. Bailey
Title and authors | Publication | Year |
---|---|---|
Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19
Kumar D, Gaikwad K, Gunnale R, Vishwakarma S, Shukla S, Srivastava S, Gopal J, Vaidya B, Saraf A, Gurjar R, Kaviraj S, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S |
NPJ Vaccines | 2025 |
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
Herrero R, Fantin R, Loría V, Aparicio A, Prevots DR, Zúñiga M, Wong R, Morera M, Butt J, Binder M, Abdelnour A, Calderón A, Castro R, Cortes B, Ocampo R, Vanegas JC, Gail MH, Pfeiffer RM, Flock J, Remans K, Eberhardt L, Rastgou S, Magalhaes V, Porras C, Hildesheim A, Waterboer T |
BMC Infectious Diseases | 2025 |
Efficient boosting of Omicron-reactive memory B cells after breakthrough infection protects from repeated exposure
Chu Q, Li K, He Q, Ren L, Wang J, Wang S, Liu X, Liu Y, He J, Li D, Shao Y |
iScience | 2025 |
Poor immune response to inactivated COVID-19 vaccine in patients with hypertension
Yang L, Zeng T, Li Y, Guo Q, Jiang D |
Frontiers in Medicine | 2024 |
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens
Reyes RA, Turner L, Ssewanyana I, Jagannathan P, Feeney ME, Lavstsen T, Greenhouse B, Bol S, Bunnik EM |
2024 | |
Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles
Serwanga J, Oluka GK, Baine C, Ankunda V, Sembera J, Kato L, Katende JS, Odoch G, Auma BO, Gombe B, Musenero M, Kaleebu P |
PloS one | 2024 |
Atypical and non-classical CD45RB(lo) memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19.
Priest DG, Ebihara T, Tulyeu J, Søndergaard JN, Sakakibara S, Sugihara F, Nakao S, Togami Y, Yoshimura J, Ito H, Onishi S, Muratsu A, Mitsuyama Y, Ogura H, Oda J, Okusaki D, Matsumoto H, Wing JB |
Nature Communications | 2024 |
Differences in phenotype between long-lived memory B cells against Plasmodium falciparum merozoite antigens and variant surface antigens
Reyes RA, Turner L, Ssewanyana I, Jagannathan P, Feeney ME, Lavstsen T, Greenhouse B, Bol S, Bunnik EM |
PLOS Pathogens | 2024 |
Cellular and Humoral Responses to Recombinant and Inactivated SARS-CoV-2 Vaccines in CKD Patients: An Observational Study
Zhang S, He J, Tang B, Zhou Q, Hu Y, Yu Y, Chen J, Liu Y, Li C, Ren H, Liao X |
Journal of Clinical Medicine | 2023 |
A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials
Bisceglia H, Barrier J, Ruiz J, Pagnon A |
Journal of Immunological Methods | 2023 |
Multivariate indicators of disease severity in COVID-19
Bean J, Kuri-Cervantes L, Pennella M, Betts MR, Meyer NJ, Hassan WM |
Scientific Reports | 2023 |
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.
Zurbuchen Y, Michler J, Taeschler P, Adamo S, Cervia C, Raeber ME, Acar IE, Nilsson J, Warnatz K, Soyka MB, Moor AE, Boyman O |
Nature Immunology | 2023 |
Immune responses to inactivated COVID-19 vaccine were decreased in Chinese patients with chronic respiratory diseases
Yang L, Xu L, Guo Q, Deng B, Hong Y, Wang L, Wang Y, Jiang D, Ren H |
International journal of medical sciences | 2023 |
Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection
Wang H, Liu C, Xie X, Niu M, Wang Y, Cheng X, Zhang B, Zhang D, Liu M, Sun R, Ma Y, Ma S, Wang H, Zhu G, Lu Y, Huang B, Su P, Chen X, Zhao J, Wang H, Shen L, Fu L, Huang Q, Yang Y, Wang H, Wu C, Ge W, Chen C, Huo Q, Wang Q, Wang Y, Geng L, Xie Y, Xie Y, Liu L, Qi J, Chen H, Wu J, Jiang E, Jiang W, Wang X, Shen Z, Guo T, Zhou J, Zhu P, Cheng T |
Immunity | 2023 |
SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
Mohn KG, Bredholt G, Onyango TB, Brokstad KA, Zhou F, Holter JC, Tonby K, Dyrhol-Riise AM, Cox RJ |
Journal of Infection | 2023 |
Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection
Zhou Y, Chen Z, He Y, Peng X, Chang Y, Tan A, Li H, Cai D, Hu P, Chen M, Peng M, Xu H, Ren H |
Frontiers in Cellular and Infection Microbiology | 2023 |
Seroprevalence of SARS-CoV-2 immunoglobulin G antibody during COVID-19 pandemic in Fayoum District, Egypt: a community-based pilot survey.
Bakr S, Ezzat EM, Salem KM, Masoud M, Abdelaziz HEM |
The Pan African medical journal | 2023 |
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells.
Krause RGE, Moyo-Gwete T, Richardson SI, Makhado Z, Manamela NP, Hermanus T, Mkhize NN, Keeton R, Benede N, Mennen M, Skelem S, Karim F, Khan K, Riou C, Ntusi NAB, Goga A, Gray G, Hanekom W, Garrett N, Bekker LG, Groll A, Sigal A, Moore PL, Burgers WA, Leslie A |
npj Vaccines | 2023 |
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
Roslan M, Mohd Nisfu FR, Arzmi MH, Abdul Wahab R, Zainuddin N |
The Malaysian Journal of Medical Sciences : MJMS | 2023 |
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Yang L, Liu Y, Guo Q, Jiang D |
Open Medicine | 2023 |
Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience
Elhadidy T, Abdelwahab HW, Shahin D, Hewidy A, Khashaba E, Elmorsey RA, Abo El Kheir N, Eid EA, El-Mesery A, Elmaria MO |
F1000Research | 2023 |
Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience.
Elhadidy T, Abdelwahab HW, Shahin D, Hewidy A, Khashaba E, Elmorsey RA, Abo El Kheir N, Eid EA, El-Mesery A, Elmaria MO |
F1000Research | 2023 |
Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis.
Zhu Q, Wang L, Hu X, Zhang Y, Huang T, He T, Chen Z, Zhang G, Peng M, Chen M, Cai D, Shi X, Ren H |
Journal of Clinical and Translational Hepatology | 2023 |
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases
Chen Z, Wang Y, He T, Li H, Ao L, Pan Q, Zhou Y, Zhu Q, Xiang D, Zhang G, Ling N, Chen M, Hu P, Peng M, Cai D, Zhang D, Ren H |
Journal of Clinical and Translational Hepatology | 2023 |
SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies
Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica Davies, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie Doores, J. Yimmy Chow, Shamez N Ladhani, Maria Zambon, Laura McCoy, Mala K Maini. |
Journal of Clinical Investigation | 2022 |
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
N Khoo, J Lim, U Gill, R de Alwis, N Tan, J Toh, J Abbott, C Usai, E Ooi, J Low, N Bert, P Kennedy, A Bertoletti |
The American Journal of Medicine | 2022 |
Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19
M Bartlett, S Suwanmanee, N Akindele, S Ghimire, A Chan, C Guo, S Gould, A Cox, D Griffin |
Viral Immunology | 2022 |
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
S Gil-Manso, I Blanco, R López-Esteban, D Carbonell, L López-Fernández, L West, R Correa-Rocha, M Pion |
Frontiers in immunology | 2022 |
Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals
A Embong, P Nguyen-Contant, J Wang, P Kanagaiah, F Chaves, T Fitzgerald, Q Zhou, G Kosoy, A Branche, B Miller, M Zand, M Sangster, D Topham |
Pathogens | 2022 |
The Impact of SARS-CoV-2 Primary Vaccination in a Cohort of Patients Hospitalized for Acute COVID-19 during Delta Variant Predominance
D Stupica, S Collinet-Adler, N Kejžar, Z Jagodic, M Poljak, M Klevišar |
Journal of Clinical Medicine | 2022 |
COVID-19 Infection in Children: Diagnosis and Management
F Zhu, J Ang |
Current Infectious Disease Reports | 2022 |
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
Ao L, Lu T, Cao Y, Chen Z, Wang Y, Li Z, Ren X, Xu P, Peng M, Chen M, Zhang G, Xiang D, Cai D, Hu P, Shi X, Zhang D, Ren H |
Emerging Microbes & Infections | 2022 |
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.
Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR |
Pathogens and Global Health | 2022 |
Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease.
Chen Z, Zhang Y, Song R, Wang L, Hu X, Li H, Cai D, Hu P, Shi X, Ren H |
Signal Transduction and Targeted Therapy | 2022 |
COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE |
Immunological Reviews | 2022 |
A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses.
Torresi J, Edeling MA, Nolan T, Godfrey DI |
Frontiers in immunology | 2022 |
Mechanism of COVID-19 Causing ARDS: Exploring the Possibility of Preventing and Treating SARS-CoV-2
Zheng J, Miao J, Guo R, Guo J, Fan Z, Kong X, Gao R, Yang L |
Frontiers in Cellular and Infection Microbiology | 2022 |
The role of interleukin-22 in lung health and its therapeutic potential for COVID-19
Fang S, Ju D, Lin Y, Chen W |
Frontiers in immunology | 2022 |
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP II, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K |
mSphere | 2022 |
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
Dotiwala F, Upadhyay AK |
Frontiers in immunology | 2022 |
Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
Li H, Wang Y, Ao L, Ke M, Chen Z, Chen M, Peng M, Ling N, Hu P, Cai D, Zhang D, Ren H |
Frontiers in immunology | 2022 |
Short-term safety and immunogenicity of inactivated and peptide-based SARS-CoV-2 vaccines in patients with endocrine-related cancer
Song R, Liu L, Pan Q, Liu J, Tan J, Deng J, Deng Q, Lin Z, Chen M, Peng M, Ren H, Ming J |
Frontiers in immunology | 2022 |
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Zhu Q, Xu Y, Wang T, Xie F |
Frontiers in immunology | 2022 |
Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
Zhu Q, Zhang Y, Kang J, Chen Z, Peng M, Chen M, Zhang G, Xiang D, Xiao S, Li H, Mei Y, Yang J, Qi X, Cai D, Ren H |
Genes & Diseases | 2022 |
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
Guo Q, Yang L, Peng R, Gao T, Chu X, Jiang D, Ke D, Ren H |
Frontiers in public health | 2022 |
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
Gupta M, Balachandran H, Louie RH, Li H, Agapiou D, Keoshkerian E, Christ D, Rawlinson W, Mina MM, Post JJ, Hudson B, Gilroy N, Konecny P, Bartlett AW, Sasson SC, Ahlenstiel G, Dwyer D, Lloyd AR, Martinello M, Luciani F, Bull RA |
Immunology and Cell Biology | 2022 |
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.
Karger AB, Brien JD, Christen JM, Dhakal S, Kemp TJ, Klein SL, Pinto LA, Premkumar L, Roback JD, Binder RA, Boehme KW, Boppana S, Cordon-Cardo C, Crawford JM, Daiss JL, Dupuis AP 2nd, Espino AM, Firpo-Betancourt A, Forconi C, Forrest JC, Girardin RC, Granger DA, Granger SW, Haddad NS, Heaney CD, Hunt DT, Kennedy JL, King CL, Krammer F, Kruczynski K, LaBaer J, Lee FE, Lee WT, Liu SL, Lozanski G, Lucas T, Mendu DR, Moormann AM, Murugan V, Okoye NC, Pantoja P, Payne AF, Park J, Pinninti S, Pinto AK, Pisanic N, Qiu J, Sariol CA, Simon V, Song L, Steffen TL, Stone ET, Styer LM, Suthar MS, Thomas SN, Thyagarajan B, Wajnberg A, Yates JL, Sobhani K |
medRxiv : the preprint server for health sciences | 2022 |
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
S Winklmeier, K Eisenhut, D Taskin, H Rübsamen, R Gerhards, C Schneider, PR Wratil, M Stern, P Eichhorn, OT Keppler, M Klein, S Mader, T Kümpfel, E Meinl |
iScience | 2021 |
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease
RA Reyes, K Clarke, SJ Gonzales, AM Cantwell, R Garza, G Catano, RE Tragus, TF Patterson, S Bol, EM Bunnik, MC van Zelm |
PloS one | 2021 |
Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model
S Dhakal, CA Ruiz-Bedoya, R Zhou, PS Creisher, JS Villano, K Littlefield, JR Castillo, P Marinho, AE Jedlicka, AA Ordonez, M Bahr, N Majewska, MJ Betenbaugh, K Flavahan, AR Mueller, MM Looney, D Quijada, F Mota, SE Beck, J Brockhurst, AM Braxton, N Castell, M Stover, FR DAlessio, KA Pate, PC Karakousis, JL Mankowski, A Pekosz, SK Jain, SL Klein, CB Coyne |
mBio | 2021 |
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
SL Fanning, R Korngold, Z Yang, K Goldgirsh, S Park, J Zenreich, M Baker, P McKiernan, M Tan, B Zhang, ML Donato, DS Perlin, SR Shih |
PLoS pathogens | 2021 |
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
ME Ligotti, F Pojero, G Accardi, A Aiello, C Caruso, G Duro, G Candore |
Frontiers in Cell and Developmental Biology | 2021 |
Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion
OF Wirz, K Röltgen, BA Stevens, S Pandey, MK Sahoo, L Tolentino, M Verghese, K Nguyen, M Hunter, TT Snow, AR Singh, CA Blish, JR Cochran, JL Zehnder, KC Nadeau, BA Pinsky, TD Pham, SD Boyd |
Frontiers in immunology | 2021 |
Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University
J Messersmith, C Stoddart-Osumah, M Lennon, D Wirtz |
Journal of Clinical Investigation | 2021 |
Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation
LM Meyers, AH Gutiérrez, CM Boyle, F Terry, BG McGonnigal, A Salazar, MF Princiotta, WD Martin, AS Groot, L Moise |
npj Vaccines | 2021 |
Immunity to SARS‐CoV‐2 induced by infection or vaccination
XC Dopico, S Ols, K Loré, GB Hedestam |
Journal of Internal Medicine | 2021 |
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU
L Vigón, J García-Pérez, S Rodríguez-Mora, M Torres, E Mateos, MC de la Osa, M Cervero, RM Molina, C Navarro, MA Murciano-Antón, V García-Gutiérrez, V Planelles, J Alcamí, M Pérez-Olmeda, M Coiras, MR López-Huertas |
Frontiers in immunology | 2021 |
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
P Ahluwalia, K Vaibhav, M Ahluwalia, AK Mondal, N Sahajpal, AM Rojiani, R Kolhe |
Frontiers in immunology | 2021 |
Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection
PP Sfikakis, KM Verrou, G Ampatziadis-Michailidis, O Tsitsilonis, D Paraskevis, E Kastritis, E Lianidou, P Moutsatsou, E Terpos, I Trougakos, V Chini, M Manoloukos, P Moulos, GA Pavlopoulos, G Kollias, P Hatzis, MA Dimopoulos |
Frontiers in immunology | 2021 |
The germinal centre B cell response to SARS-CoV-2
BJ Laidlaw, AH Ellebedy |
Nature Reviews Immunology | 2021 |
Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
HM Kantarjian, G Zugmaier, M Brüggemann, BL Wood, HA Horst, Y Zeng, G Martinelli |
Cancers | 2021 |
SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults
S Björkander, L Du, F Zuo, S Ekström, Y Wang, H Wan, N Sherina, L Schoutens, J Andréll, N Andersson, A Georgelis, A Bergström, H Marcotte, I Kull, L Hammarström, E Melén, Q Pan-Hammarström, C Almqvist, N Andersson, N Ballardini, A Bergström, S Björkander, P Brodin, A Castel, S Ekström, A Georgelis, L Hammarström, Q Pan-Hammarström, J Hallberg, C Jansson, M Kere, I Kull, A Lauber, A Lövquist, E Melén, J Mjösberg, I Mogensen, L Palmberg, G Pershagen, N Roxhed, J Schwenk |
Journal of Allergy and Clinical Immunology | 2021 |
Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina
Y Longueira, ML Polo, G Turk, N Laufer |
Heliyon | 2021 |
Immunologisch relevante Aspekte der neuen COVID-19-Impfstoffe: Ein Positionspapier der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und des Ärzteverbands Deutscher Allergologen (AeDA)
E Untersmayr, E Förster-Waldl, M Bonelli, K Boztug, PM Brunner, T Eiwegger, K Eller, L Göschl, K Grabmeier-Pfistershammer, W Hötzenecker, G Jordakieva, AR Moschen, B Pfaller, W Pickl, W Reinisch, U Wiedermann, L Klimek, KC Bergmann, R Brehler, N Novak, HF Merk, U Rabe, WW Schlenter, J Ring, W Wehrmann, NK Mülleneisen, H Wrede, T Fuchs, E Jensen-Jarolim |
Allergo Journal | 2021 |
Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper
E Untersmayr, E Förster-Waldl, M Bonelli, K Boztug, PM Brunner, T Eiwegger, K Eller, L Göschl, K Grabmeier-Pfistershammer, W Hötzenecker, G Jordakieva, AR Moschen, B Pfaller, W Pickl, W Reinisch, U Wiedermann, L Klimek, KC Bergmann, R Brehler, W Pfützner, N Novak, H Merk, U Rabe, W Schlenter, J Ring, W Wehrmann, N Mülleneisen, H Wrede, T Fuchs, E Jensen-Jarolim |
Allergo Journal International | 2021 |
Mesenchymal stem cell therapy for severe COVID-19
L Shi, L Wang, R Xu, C Zhang, Y Xie, K Liu, T Li, W Hu, C Zhen, FS Wang |
Signal Transduction and Targeted Therapy | 2021 |
Impact of reproduction number on the multiwave spreading dynamics of COVID-19 with temporary immunity: A mathematical model
B Shayak, MM Sharma, M Gaur, AK Mishra |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021 |
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing
A Qureshi, W Baskett, W Huang, I Lobanova, S Naqvi, C Shyu |
Clinical Infectious Diseases | 2021 |
ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
Gil-Manso S, Miguens Blanco I, Motyka B, Halpin A, López-Esteban R, Pérez-Fernández VA, Carbonell D, López-Fernández LA, West L, Correa-Rocha R, Pion M |
Virulence | 2021 |
Advances in understanding the formation and fate of B-cell memory in response to immunization or infection.
Kealy L, Good-Jacobson KL |
2021 | |
SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease.
Reyes RA, Clarke K, Gonzales SJ, Cantwell AM, Garza R, Catano G, Tragus RE, Patterson TF, Bol S, Bunnik EM |
bioRxiv : the preprint server for biology | 2021 |